Kalbe Farma Tbk PT ADR (PTKFY)

  • Get an in-depth profile of Kalbe Farma Tbk PT ADR, including a general overview of the company's business and key management, as well as employee data and location and contact information.

Select Exchange

Symbol Exchange Currency
PTKFY OTC Markets USD Delayed KLBF Jakarta IDR Delayed
28.97 0.00 (0.00%)
Close USD Disclaimer

Kalbe Farma Tbk PT ADR Company Profile

Industry
Pharmaceuticals
Sector
Healthcare
Employees
12501
Equity Type
ADR
PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals, Consumer Health, Nutritionals, and Distribution and Logistic. It offers generic, branded, and licensed drugs, including Brainact, Cefspan, Mycoral, Cernevit, Cravit, Neuralgin, Broadced, Neurotam, Hemapo, and CPG that are distributed to hospitals, pharmacies, and drug stores. The company also provides over-the-counter drugs; energy drinks, ready-to-drink products, supplements, and other preventive products; and nutritional products for infants, toddlers, children, teenagers, adults, pregnant and lactating women, and elders, as well as for consumers with special medical needs. In addition, it offers contract services, including clinical study management, bioavailability/bioequivalence studies, and contract analysis to pharmaceutical companies; and animal health products, as well as operates Mitrasana Clinics, a health care service. Further, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. PT Kalbe Farma Tbk. was incorporated in 1966 and is headquartered in Jakarta, Indonesia.
Contact Information
Address
Cempaka Putih Jakarta,10510 Indonesia
Phone
62 21 4287 3888
Fax
62 21 4287 3678
Web
https://www.kalbe.co.id
Top Executives
Name
Age
Since
Title
- Mulialie 0 2021 Director
Jos Iwan Atmadjaja 51 2021 Director
Sie Djohan 54 2007 Director of Corporate Business Development, Management System & Regulatory Affairs and Director
Ferdinand B. Aryanto 49 2008 Commissioner
Santoso Oen 57 2000 Commissioner
Bernadus Karmin Winata 57 2017 Director
Ronny Hadiana 50 2015 Commissioner
Lucky Surjadi Slamet 68 2014 Independent Commissioner
- Vidjongtius 57 1997 President Director
Lilis Halim 61 2019 Independent Commissioner
Adi Harsono 66 2020 Commissioner
Bernadette Ruth Irawati Setiady 59 1997 President Commissioner

Customize

Clear All
0Selected
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles